Shares of Septerna Inc. were soaring in Wednesday trading after the biotech clinched a partnership with Wegovy and Ozempic parent Novo Nordisk to collaborate on oral obesity and Type 2 diabetes ...

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Donald Trump recently made fun of his friend who takes Ozempic, adding that the weight-loss drug doesn’t seem to be working ...

Trump signs executive order, discussed "overweight" friend who was taking the "fat shot drug." It wasn't confirmed whether he ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

New research has shown that Ozempic can cause taste changes in people taking it, even going so far as to make some hate the ...

Experts say weight management drugs have created an unsustainable surge in health care spending, with some insurance ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

It found that people on GLP-1 drugs like Wegovy and Ozempic reported eating fewer processed foods, red meat and sugary drinks ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...